Hinge Health, Inc. (HNGE) stock is soaring 22.66% in its New York Stock Exchange debut on Thursday, following a successful initial public offering (IPO) that raised $437 million. The digital health startup, which specializes in joint and muscle pain treatment, priced its shares at $32 each, the top end of its marketed range.
The company sold approximately 13.7 million shares, with about 8.5 million offered by Hinge Health itself and the remainder by existing shareholders. The strong debut reflects investor confidence in the company's business model and growth potential in the digital health sector.
Hinge Health's impressive first-day performance comes amid a resurgence in the IPO market. The company's successful listing, along with other recent IPOs, signals a renewed appetite for new issues despite ongoing market volatility. This positive reception could encourage other companies waiting in the wings to move forward with their public offerings.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。